degradation by facilitating the stepwise phosphorylation of ␤-catenin independently of the Wnt-controlled Axin complex.
Results
presenilin Deficiency Selectively Reduces Turnover of S45 Phosphorylated ␤-Catenin We previously reported that PS1 deficiency resulted in elevated cytosolic ␤-catenin levels together with higher steady-state levels of total phosphorylated ␤-catenin, suggesting that PS1 might be involved in targeting phosphorylated ␤-catenin for degradation ). This prompted us to investigate the role of presenilin in modulating the turnover of distinct phosphorylated species of ␤-catenin with antibodies specifically recognizing either S45-phosphorylated ␤-catenin (P-45) or that phosphorylated at positions 33, 37, and 41 (P-33/ 37/41) The characterization of phospho-specific ␤-catenin antibodies, response of phospho-␤-catenin to Wnt signaling, and immunolocalization of phosphorylated ␤-catenin species are documented in the Supplemental Figures S2A and S2B at http://www.cell.com/cgi/content/ full/110/6/751/DC1). Notably, the D257A mutant of PS1 cells was reduced to 62% Ϯ 13% (n ϭ 5) of PS ϩ/ϩ levels ( Figure 1A) . Thus, the ratio of P-33/37/41 per P-45 that impairs Notch proteolysis contained full activity in restoring P-45 ␤-catenin turnover (Supplemental Figure ␤-catenin was reduced almost 5-fold, to 22% Ϯ 9% (n ϭ 5) of PS ϩ/ϩ control. The changes detected by the S2B). Furthermore, a ␥-secreatase inhibitor that inhibits both APP and Notch cleavages had no effect on P-45 phospho-41/45 antibody was attributable solely to S45-phosphorylated ␤-catenin, as preabsorption with phosturnover in either PS ϩ/ϩ or PS Ϫ/Ϫ cells (Supplemental Figure S2C ), indicating that intramembrane proteolysis pho-45 peptide alone but not phospho-41 or phospho-33/37/41 peptides eliminated all immunoreactivity in and ␤-catenin turnover are two mutually exclusive activities of presenilin. Unlike in PS Ϫ/Ϫ cells, a truncating APC PS ϩ/ϩ and PS Ϫ/Ϫ cell lysates ( Figure 1B ). No differences in Axin protein levels were detected between PS ϩ/ϩ and mutation or a S37F ␤-catenin mutation resulted in stabilization of both phosphorylated species of ␤-catenin (Sup-PS Ϫ/Ϫ cells ( Figure 1A ). To determine whether the elevation of S45 phosphoryplemental Figure S3 ), indicating mechanistically distinct defects. These results demonstrate that presenilin defilated ␤-catenin in presenilin-deficient cells was due to impaired turnover, ␤-catenin levels were assessed after ciency leads to a unique imbalance of phosphorylated ␤-catenin species, possibly by impairing the stepwise cycloheximide (CHX) treatment. In PS ϩ/ϩ cells, the turnover of P-45 (t 1/2 ϭ 25 min) and P-33/37/41 (t 1/2 Ͻ 15 min) phosphorylation from S45 to 33/37/41 positions. epitopes was rapid ( Figure 1C ). In contrast, the turnover of P-45 ␤-catenin but not P-33/37/41 ␤-catenin was imReduced ␤-Catenin Substrate for Ubiquitin Conjugation by the Loss of presenilin paired in PS Ϫ/Ϫ cells with a half-life of Ͼ120 min for the species phosphorylated at S45 ( Figure 1C) Figure 3A ). We next asked whether the PS1 complex contains phosphorylated ␤-catenin species are targeted for degradation by the proteasome (Figures 2A and 2B ). Howkinase activities capable of specifically phosphorylating S45 and/or residues 33/37/41. Surprisingly, PS1 immune ever, the accumulation of high-molecular-weight species of P-33/37/41 was dramatically greater than that complex phosphorylated S45 in both recombinant ␤-catenin and endogenous ␤-catenin that coprecipitated with seen with P-45 ␤-catenin species (Figure 2A ). These higher molecular weight species were indeed ubiquiti-PS1 ( Figure 3B ). The S45 phosphorylation event was not mediated by GSK-3␤ since this activity was LiCl nated, since multiubiquitin immune complexes contained large amounts of slower migrating P-33/37/41 insensitive, and purified GSK-3␤ was incapable of phosphorylating recombinant ␤-catenin at this position ( diated by GSK-3␤, we hypothesized that PS1 functions contained markedly higher S45 kinase activity on recombinant ␤-catenin but also a larger amount of the catalytic to bring together not only ␤-catenin and GSK-3␤ but also a priming kinase that phosphorylates S45 of ␤-catenin.
subunit of PKA ( Figure 3E ), indicating that PKA might serve as a priming kinase in the PS1 complex. Indeed, Since neither Axin nor CK1␣ could be detected in PS1 immune complexes, we tested the potential impact of purified PKA robustly phosphorylated recombinant ␤-catenin on S45 but had no activity on residues 33/37/41 two candidate kinase pathways previously shown to phosphorylate PS1 and protein kinase C (PKC) and A ( Figure 3F ). GSK-3␤ alone phosphorylated recombinant ␤-catenin at residues 33/37/41 poorly ( Figure 3F ). How-(PKA) on S45 phosphorylation of ␤-catenin (Seeger et al., 1997; Walter et al., 1998). In HEK 293 cells, activation ever, prior phosphorylation of S45 by PKA strongly enhanced GSK-3␤-dependent phosphorylation of ␤-cateor inhibition of the PKC pathway had no effect on the levels of the P-45 ␤-catenin (data not shown). In connin at residues 33/37/41 ( Figure 3F ), in accordance with the priming kinase model of ␤-catenin phosphorylation. trast, activation of PKA pathway by forskolin robustly elevated P-45 levels (see Supplemental Figure S5A Our model that nuclear accumulation of P-45 stems from disconnecting the paired phosphorylation of ␤-cate-CKI␣ protein levels by ‫%07ف‬ (Figure 4C ). This was accompanied by a substantial decrease in P-45 ␤-catenin nin predicts that nuclear P-45 localization would also occur in other in vivo settings where a similar disruption is known levels equally in both PS ϩ/ϩ and PS Ϫ/Ϫ cells ( Figure 4D ), indicating that CK1␣ activity on S45 phosphorylation to be present. To test this prediction, we examined four human medulloblastomas containing ␤-catenin mutais independent of presenilin. Nevertheless, proteasome inhibition resulted in accumulation of P-45 ␤-catenin tions that allow S45 phosphorylation but incomplete subsequent phosphorylation and ubiquitination (D32A, both in the presence and absence of CK1␣ RNAi in PS tissues from PS1 Ϫ/Ϫ embryos and control littermates this study was to define the mechanism of presenilin regulation of ␤-catenin turnover in hopes of providing rescued with human PS1 (PS1 Ϫ/Ϫ ; hPS1) were biochemibetter insights into the in vivo phenotypes described cally examined for levels of total and phosphorylated previously in presenilin-deficient mice and in Drosoph-␤-catenin. We found a 2-fold elevation in ␤-catenin level ila. The results showed that presenilin functions in a in PS1 null spinal cords ( Figure 6B ). This was accompaparallel and additive pathway to the Axin complex to nied by a marked reduction in the ratio of P-33/37/41 control ␤-catenin degradation by facilitating the paired per P-45 ␤-catenin to 38% Ϯ 10% of PS1 rescued spinal phosphorylation steps of ␤-catenin. These observations cords (n ϭ 4 each, Figure 6C ), an in vivo confirmation therefore provide a mechanistic basis for explaining that PS1 deficiency impedes the paired phosphorylation ␤-catenin regulation through the presenilin complex, events. These results therefore argue that the loss of findings that significantly extend the current canonical PS1 in the CNS not only recapitulates the biochemical model of ␤-catenin turnover and presenilin biology. changes found in cultured cells but also leads to
In this study, we documented that presenilin defichanges in the developing spinal cord that are highly ciency reduces ␤-catenin phosphorylation at residues reminiscent of abnormal Wnt signaling. 33/37/41 relative to that phosphorylated at the S45, an imbalance that was due to the impairment in linking Discussion S45 phosphorylation to subsequent GSK-3␤-mediated phosphorylation. Because S45 phosphorylation is rePresenilin-Dependent Control of ␤-Catenin quired for the subsequent phosphorylation at 33/37/41 Phosphorylation and Degradation and ubiquitination, this finding not only provided the In spite of the evidence supporting the negative regulamechanistic explanation of the slowed rate of ␤-catenin tion of ␤-catenin signaling by PS1, the molecular mechaubiquitination by the loss of presenilin (Soriano et al.,  2001 ), but also indicated that presenilin functions as an nism responsible for this activity is unclear. The goal of intermediate between S45 and 33/37/41 phosphorylabridging the two phosphorylation events. Thus, S45 phosphorylation of ␤-catenin outside of either Axin or tion events. Two models of presenilin action can explain these findings (Figure 7) . In the first scenario, presenilin presenilin complexes appear to decouple the subsequent 33/37/41 phosphorylation, resulting in accumulasequesters ␤-catenin already phosphorylated at S45, perhaps a pool that has escaped the Axin complex, for tion of both total and P-45 ␤-catenin together with a disproportionate reduction in P-33/37/41. subsequent phosphorylation at 33/37/41 by GSK-3␤. Second, presenilin functions as a scaffold connecting Based on the current results, we propose a model in which presenilin functions in parallel to the Axin complex a priming kinase pathway with GSK-3␤ activity within the same complex, much as that proposed for Axin (Liu and independent of the Wnt-regulated pathway ( Figure  7 ). Several lines of evidence support this conclusion. et al., 2002). The latter scenario is supported by our observation that the presenilin complex together with First, inactivation of the Axin complex by Wnt-3a did not abrogate the presenilin activity on ␤-catenin phosthe PKA pathway was not only capable of S45 phosphorylation in vitro and in vivo but also robustly facilitated phorylation, consistent with previous documentation that PS1 overexpression decreased Wnt-induced stabi-GSK-3␤-dependent 33/37/41 phosphorylation, a mechanism in concordance with the priming kinase model of lization of ␤-catenin and nuclear signaling (Killick et al., 2001). Second, stable overexpression of PS1 led to a ␤-catenin phosphorylation. However, it is notable that loss of presenilin does not preclude the priming step. reduction in ␤-catenin even in Axin-deficient cells. Third, CK1␣/Axin activity on S45 ␤-catenin phosphorylation Similarly, we observed that Axin deficiency in SNU475 cells did not impair S45 phosphorylation but resulted in was independent of presenilin. Fourth, presenilin activity on S45 phosphorylation was insensitive to CK1␣/Axin a marked reduction in P-33/37/41 ␤-catenin (data not shown), suggesting that scaffolding proteins are not reexpression, a result consistent with the proposal that the PKA pathway may represent a second S45 priming quired for the initial priming event but are needed for 
